Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes

BACKGROUND: Conflicting results have been reported on the efficacy of insulin degludec/insulin aspart (IDegAsp) compared to basal insulin in type 2 diabetes. We investigated the effects of changing basal insulin to IDegAsp on glycemic control and sought to identify factors related to those effects....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Endocrinol Metab (Seoul)
Päätekijät: Jang, Han Na, Yang, Ye Seul, Lee, Seong Ok, Oh, Tae Jung, Koo, Bo Kyung, Jung, Hye Seung
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Endocrine Society 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935773/
https://ncbi.nlm.nih.gov/pubmed/31884738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2019.34.4.382
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia